Bandingkan kaedah

	Analisis Kos-Manfaat (CBA)	Pemodelan Analitis Keputusan dalam Ekonomi Kesihatan
Bidang	Ekonomi Kesihatan	Ekonomi Kesihatan
Keluarga	Process / pipeline	Process / pipeline
Tahun asal	1970s	1975
Pengasas	Boardman, Greenberg, and colleagues (welfare economics)	Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital)
Jenis	Method	Method
Sumber perintis	Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press.	Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234.
Alias	CBA, economic appraisal, benefit-cost ratio	decision analysis, decision tree, decision model, health economic model
Berkaitan	5	5
Ringkasan	Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types.	Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions.